These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 25911949)
1. Diagnosis and management with botulinum toxin in 11 cases of laryngeal synkinesis. Lekue A; García-López I; Santiago S; Del Palacio A; Gavilán J Eur Arch Otorhinolaryngol; 2015 Sep; 272(9):2397-402. PubMed ID: 25911949 [TBL] [Abstract][Full Text] [Related]
2. A new electromyographic definition of laryngeal synkinesis. Maronian NC; Robinson L; Waugh P; Hillel AD Ann Otol Rhinol Laryngol; 2004 Nov; 113(11):877-86. PubMed ID: 15562897 [TBL] [Abstract][Full Text] [Related]
3. Botulinum toxin in management of synkinesis in patients with unilateral and bilateral vocal fold paralysis. Lewis S; Woo P Laryngoscope; 2018 Feb; 128(2):447-450. PubMed ID: 28850724 [No Abstract] [Full Text] [Related]
4. [Effect of cricothyroid and thyroarytenoid muscle botulinum toxin injection on patients with dyspnea caused by bilateral recurrent laryngeal nerve paresis]. Xu XL; Lai JM; Qiu T; Ma YL; Jiao YC; Zhuang PY Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 May; 53(5):375-380. PubMed ID: 29764020 [No Abstract] [Full Text] [Related]
5. Crumley's Classification of Laryngeal Synkinesis: A Comparison of Laryngoscopy and Electromyography. Foerster G; Podema R; Guntinas-Lichius O; Crumley RL; Mueller AH Laryngoscope; 2021 May; 131(5):E1605-E1610. PubMed ID: 33220002 [TBL] [Abstract][Full Text] [Related]
6. Botulinum toxin injection in laryngeal dyspnea. Woisard V; Liu X; Bes MC; Simonetta-Moreau M Eur Arch Otorhinolaryngol; 2017 Feb; 274(2):909-917. PubMed ID: 27600559 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic limitation of laryngostroboscopy in comparison to laryngeal electromyography in synkinesis in unilateral vocal fold paralysis. Stanisz I; Leonhard M; Denk-Linnert DM; Schneider-Stickler B Eur Arch Otorhinolaryngol; 2021 Jul; 278(7):2387-2395. PubMed ID: 33689023 [TBL] [Abstract][Full Text] [Related]
8. The role of botulinum toxin in the management of airway compromise due to bilateral vocal fold paralysis. Ongkasuwan J; Courey M Curr Opin Otolaryngol Head Neck Surg; 2011 Dec; 19(6):444-8. PubMed ID: 21986800 [TBL] [Abstract][Full Text] [Related]
9. Aberrant recurrent laryngeal nerve reinnervation as a cause of stridor and laryngospasm. Woo P; Mangaro M Ann Otol Rhinol Laryngol; 2004 Oct; 113(10):805-8. PubMed ID: 15535143 [TBL] [Abstract][Full Text] [Related]
10. Innervation status in chronic vocal fold paralysis and implications for laryngeal reinnervation. Lin RJ; Smith LJ; Munin MC; Sridharan S; Rosen CA Laryngoscope; 2018 Jul; 128(7):1628-1633. PubMed ID: 29355973 [TBL] [Abstract][Full Text] [Related]
11. PCA Atrophy and Synkinesis as the Main Factors for Persistent Vocal Fold Immobility in RLN Paralysis. Foerster G; Mueller AH Laryngoscope; 2021 Apr; 131(4):E1244-E1248. PubMed ID: 33141465 [TBL] [Abstract][Full Text] [Related]
12. Unilateral true vocal fold synkinesis presenting with airway obstruction. Azadarmaki R; Mirza N; Soliman AM Ann Otol Rhinol Laryngol; 2009 Aug; 118(8):587-91. PubMed ID: 19746758 [TBL] [Abstract][Full Text] [Related]
13. Electromyographic laryngeal synkinesis alters prognosis in vocal fold paralysis. Statham MM; Rosen CA; Smith LJ; Munin MC Laryngoscope; 2010 Feb; 120(2):285-90. PubMed ID: 19950370 [TBL] [Abstract][Full Text] [Related]